埃尔奥罗的Mycobacterium结核病种群结构:对厄瓜多尔-秘鲁结核病传播的第一次洞察
Bernardo Castro-Rodriguez1, Kerly León-Ordóñez2, Greta Franco-Sotomayor3
1One Health Research Group. Universidad de las Américas, Quito, Ecuador.
Journal of infection and public health
|February 4, 2024
概括
在厄瓜多尔的结核病传播.
科学领域:
- 分子流行病学分子流行病学
- 结核菌复合体 (MTBC) 分析
- 公共卫生监督是对公共卫生的监督.
背景情况:
- 结核病 (TB) 在厄瓜多尔和秘鲁是一个重大的公共卫生挑战,特别是耐药结核病.
- 分子流行病学对于理解结核病传播动态和识别活跃传播集群至关重要.
- 这项研究调查了在秘鲁和厄瓜多尔之间的结核病传播,使用厄瓜多尔埃尔奥罗省的MTBC血统.
研究的目的:
- 分析厄瓜多尔埃尔奥罗省MTBC血统的人口结构.
- 调查厄瓜多尔和秘鲁之间可能存在的结核病传播联系.
- 了解边境地区结核病的分子流行病学.
主要方法:
- 从埃尔奥罗省 (2012-2015) 分析了56种MTBC菌株.
- 使用24位点MIRU-VNTR和spolligotyping进行基因型定制.
- 检查了MTBC血统多样性和人口结构.
主要成果:
- 在埃尔奥罗发现的MTBC菌株的高多样性.
- 没有检测到任何活跃的结核病传播集群.
- 在MTBC Lineage 4 (L4) 中占主导地位;MTBC L2-北京菌株很少见 (<2%).
结论:
- 埃尔奥罗的结核病动态可能与结核病复发有关,而不是像MTBC L2-Beijing这样的高度传染性菌株.
- 建议对较大,最近的MTBC培养集合进行进一步的研究.
- 建议在厄瓜多尔偏远的农村和边境地区加强结核病监测.
关键词:
边境传输的传输方式厄瓜多尔 厄瓜多尔 厄瓜多尔 是一个这就是MIRU-VNTR.移民 移民 移民分子流行病学分子流行病学结核病菌菌菌的结核病菌的结核病菌.秘鲁 秘鲁 秘鲁 秘鲁 秘鲁在Spoligotyping中,使用的是Spoligotyping.结核病是一种疾病.更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
19.9K
相关概念视频
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Pulmonary Tuberculosis II
239
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
239
Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
